Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 08, 2020 10:15 AM - Oct 09, 2020 2:00 PM

(Eastern Standard Time)

Fort Washington, PA 19034

Master Protocol Workshop

Session 4: Addressing Common Challenges— Registration and IRB Reviews

Session Chair(s)

Michelle  Detry, PhD

Michelle Detry, PhD

Director, Adaptive Trial Execution & Senior Statistical Scientist

Berry Consultants LLC, United States

AnnCatherine M. Downing, PharmD

AnnCatherine M. Downing, PharmD

Chief Operating Officer - Lilly Research Laboratories

Eli Lilly and Company, United States

Master Protocols may not fit the standard methods for trial registration or IRB review. This session will have presentations on the unique considerations for registering a Master Protocol on and submitting for IRB reviews. The registering and review of these innovative designs may require additional interactions to determine registration requirements or educational materials for IRBs unfamiliar with Master Protocols.

Learning Objective :
  • Explain the standard approach for registering a trial on and how Master Protocols may differ
  • Outline strategies for submissions to IRBs to facilitate an informed and timely review process for these innovative protocols
  • Obtain suggestions for interacting with the and IRB teams and how the interactions and estimated timelines may be different from standard trials


Heather  Dobbins, PhD

Addressing Common Challenges: IRB Review

Heather Dobbins, PhD

National Institutes of Health (NIH), United States Lead Results Analyst, NCBI/NLM

Lindsay  McNair, MD, MPH, MS


Lindsay McNair, MD, MPH, MS

Equipoise Consulting, United States

Principal Consultant

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.